These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 18162132)

  • 1. Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
    Cotrim C; Loureiro MJ; Miranda R; Almeida S; Almeida AR; Simões O; Cordeiro P; Carrageta M
    Cardiovasc Ultrasound; 2007 Dec; 5():50. PubMed ID: 18162132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
    De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
    Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.
    Gan CT; Holverda S; Marcus JT; Paulus WJ; Marques KM; Bronzwaer JG; Twisk JW; Boonstra A; Postmus PE; Vonk-Noordegraaf A
    Chest; 2007 Jul; 132(1):11-7. PubMed ID: 17625080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypoxic pulmonary hypertension: modern views on pathogenesis and options for rational pharmacological correction].
    Strielkov IeV; Frantsuzova SB; Khromov OS
    Fiziol Zh (1994); 2012; 58(2):89-100. PubMed ID: 22873057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bosentan and chronic thromboembolic pulmonary hypertension].
    Tomás C; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
    Med Clin (Barc); 2007 Nov; 129(16):639. PubMed ID: 18001681
    [No Abstract]   [Full Text] [Related]  

  • 6. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 7. Left ventricular function in pulmonary hypertension.
    Amano H; Toyoda S; Arikawa T; Inami S; Otani N; Nishi Y; Kitagawa Y; Taguchi I; Abe S; Inoue T
    Heart Vessels; 2013 Jul; 28(4):505-9. PubMed ID: 23124961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
    Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
    Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role for sildenafil in the management of perioperative pulmonary hypertension and right ventricular dysfunction after cardiac surgery.
    Madden BP; Sheth A; Ho TB; Park JE; Kanagasabay RR
    Br J Anaesth; 2004 Jul; 93(1):155-6. PubMed ID: 15192009
    [No Abstract]   [Full Text] [Related]  

  • 10. Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
    Hoeper MM
    Eur Respir J; 2007 Mar; 29(3):432-4. PubMed ID: 17329488
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan for the treatment of portopulmonary hypertension.
    Tempe DK; Datt V; Datta D
    Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
    Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
    J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary arterial hypertension: combination therapy in the modern management era.
    Sitbon O
    Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension.
    Reichenberger F; Voswinckel R; Enke B; Rutsch M; El Fechtali E; Schmehl T; Olschewski H; Schermuly R; Weissmann N; Ghofrani HA; Grimminger F; Mayer E; Seeger W
    Eur Respir J; 2007 Nov; 30(5):922-7. PubMed ID: 17690123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
    Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
    Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary arterial hypertension following pulmonary thromboembolism].
    Wilkens H
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S328-9. PubMed ID: 17139599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of Eisenmenger syndrome in the modern treatment era: a case report.
    Gatzoulis MA
    Eur Respir Rev; 2011 Dec; 20(122):293-6. PubMed ID: 22130823
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.